Company / Shareholders' Equity
LeMaitre Vascular Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$393.5M
FY2025
5-year range
$148.1M / $393.5M
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#113 of 161
Health Care
What the data says
At $394M, LeMaitre Vascular's shareholders' equity ranks #113 of 161 in the Health Care sector. Shareholders' Equity has increased for 8 consecutive years, from $78M in FY2017 to $394M in FY2025.
Based on SEC 10-K filings.
$394M in FY2025 with a 5-year CAGR of +24.8%.
Improved from $298M to $394M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +31.6%
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Sector benchmark
#113 of 161 in Health CareTop 70% of 161This company $393.5M Sector average $5.1B
▼
-92.2% below sector average
Key checks
Key Insights
- LeMaitre Vascular's shareholders' equity has grown for 8 consecutive years.
- 5-year CAGR of +24.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 16.7% year-over-year.
- Ranks #113 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $393.5M | +16.7% |
| FY2024 | $337.3M | +13.2% |
| FY2023 | $297.9M | +72.6% |
| FY2022 | $172.6M | +16.5% |
| FY2021 | $148.1M | +13.7% |
| FY2020 | $130.2M | +18.6% |
| FY2019 | $109.8M | +25.5% |
| FY2018 | $87.5M | +12.3% |
| FY2017 | $77.9M | -11.0% |
| FY2016 | $87.5M | +54.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026